Indications
Therapeutic Asset Ratings
3,272 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Nivolumab
Mixed Phenotype Acute Leukemia
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Rheumatoid Arthritis
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Sjogren Syndrome
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Mycosis Fungoides And Variants
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Systemic Lupus Erythematosus
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Systemic Sclerosis
National Cancer Institute (NCI)
P1
CC
(43)
Nivolumab
Virus Associated Tumor
National Cancer Institute (NCI)
P1
CC
(43)
Nogitecan
Malignant Pancreatic Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Obinutuzumab
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)
P1
CC
(43)
Oxodotreotide
Head And Neck Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Oxodotreotide
Kidney Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Oxodotreotide
Olfactory Neuroblastoma
National Cancer Institute (NCI)
P1
CC
(43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Renal Pelvis Urothelial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Ureter Transitional Cell Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Urethra Transitional Cell Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Malignant Renal Pelvis Neoplasm
National Cancer Institute (NCI)
P1
CC
(43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Ureter Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493
Urethra Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Pazopanib
Cancer Or Benign Tumor
National Cancer Institute (NCI)
P1
CC
(43)
Pegfilgrastim
Primary Effusion Lymphoma
National Cancer Institute (NCI)
P1
CC
(43)
Pegfilgrastim
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)
P1
CC
(43)
Pelcitoclax
Endometrial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pelcitoclax
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pelcitoclax
Ovarian Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Pelcitoclax
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Showing 2901 to 2925 of 3,272 assets
Previous
Page 117 of 131
Next
